GL1X · GenesisL1 explorer

Research workbench

Structure of the SARS-cov-2 main protease in complex with inhibitor MPI20

Analyse Structure of the SARS-cov-2 main protease in complex with inhibitor MPI20 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7RVT
Type
protein
Length
600 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
3C-like proteinase
UniProt
P0DTD1
Ligands
7XK
Pockets
8 · best druggability 0.77

Structure

x-ray diffraction · 1 distinct chain · 25% helix, 29% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, B3C-like proteinaseprotein30025% helix, 29% strandP0DTD1

Ligands and binding sites

  • 7XK · N~2~-[(2S)-2-{[(benzyloxy)carbonyl]amino}-2-cyclopropylacetyl]-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-4-methyl-L-leucinamide · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

8 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110000.770.7985empty
24180.570.7452empty
3960.420.7815empty
41260.410.7525empty
51350.390.74287XK

Interfaces

1 interface between chains.

  • A–B · 1674 Ų buried · 46 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 covalent (covalent ligand).

Compared structures

  • 7RVT · Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI20 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.